REBETOL Side Effects

7016455-2 | Abdominal Discomfort, Dementia
on Sep 16, 2010 Female patient from JAPAN , 63 years of age, was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, dementia (What is dementia?). Rebetol dosage: ; Po. During the same period patient was treated with INTERFERON (View Interferon Review and Interferon Label ).

7016441-2 | Haemolytic Anaemia, Idiopathic Thrombocytopenic Purpura, Psychiatric Symptom, Pyrexia, Renal Disorder
Patient was taking Rebetol (View Usage). Patient had the following side effects: haemolytic anaemia, idiopathic thrombocytopenic purpura, psychiatric symptom, pyrexia, renal disorder on Sep 17, 2010 from JAPAN Additional patient health information: Female patient , 74 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: 600 Mg; Qd; Po. During the same period patient was treated with INTERFERON (6 Miu; Qd; Iv, 6 Miu; Tiw; Iv) (View Interferon Review and Interferon Label ). Patient was hospitalized.

7014707-3 | Diabetic Ketoacidosis, Pneumomediastinum
Adverse event was reported on Sep 21, 2010 by a Female patient taking Rebetol (View Usage) (Dosage: Note: Dosage Is Uncertain.) . Location: JAPAN , 69 years of age, weighting 90.39 lb, After Rebetol was administered, patient had the following side effects: diabetic ketoacidosis, pneumomediastinum. During the same period patient was treated with PEG INTRON (Note: Dosage Is Uncertain.) (View Peg-intron Review and Peg-intron Label ). Patient was hospitalized.

7012325-4 | Haemolytic Anaemia, Idiopathic Thrombocytopenic Purpura, Psychiatric Symptom, Pyrexia, Renal Disorder
on Aug 09, 2010 Female patient from JAPAN , 74 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic anaemia, idiopathic thrombocytopenic purpura, psychiatric symptom, pyrexia, renal disorder. Rebetol dosage: 600 Mg;qd;po. During the same period patient was treated with INTERFERON (6 Miu;qd;iv; 6 Miu;tiw;iv) (View Interferon Review and Interferon Label ). Patient was hospitalized.


6980298-6 | Renal Impairment
on Aug 31, 2010 Male patient from JAPAN , 67 years of age, was treated with Rebetol (View Usage). Patient had the following side effects: renal impairment. Rebetol dosage: 800 Mg; Qd; Po, 400 Mg; Qd; Po. During the same period patient was treated with INTERFERON (6 Miu; Tiw; Indrp) (View Interferon Review and Interferon Label ).

6967416-0 | Blood Pressure Decreased, Cardiac Arrest, Left Ventricular Failure, Loss Of Consciousness, No Therapeutic Response, Pulmonary Congestion, Respiratory Arrest
Patient was taking Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: blood pressure decreased, cardiac arrest (What is cardiac arrest?), left ventricular failure, loss of consciousness, no therapeutic response, pulmonary congestion, respiratory arrest on Aug 27, 2010 from JAPAN Additional patient health information: Male patient , 68 years of age, weighting 165.3 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: 800 Mg;qd; Po. During the same period patient was treated with INTERFERON (6 Miu; Qd; Iv) (View Interferon Review and Interferon Label ), METHYCOBAL (View Methycobal Review and Methycobal Label ), URIEF (SILODOSIN) (View Urief (silodosin) Review and Urief (silodosin) Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), KEISHIBUKURYOUGAN (View Keishibukuryougan Review and Keishibukuryougan Label ), FUTHAN (View Futhan Review and Futhan Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ).

6942606-1 | Anaemia, Bronchitis, Diarrhoea, Electrocardiogram Repolarisation Abnormality, Left Ventricular Hypertrophy, Leukopenia, Pneumonia Haemophilus, Sputum Discoloured
Adverse event was reported on Aug 13, 2010 by a Male patient taking Rebetol (View Usage) (Dosage: 4 Df;qd;po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: GERMANY , 62 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, bronchitis (What is bronchitis?), diarrhoea, electrocardiogram repolarisation abnormality, left ventricular hypertrophy, leukopenia, pneumonia haemophilus, sputum discoloured. During the same period patient was treated with PEGASYS (180 Mcg;qw;sc) (View Pegasys Review and Pegasys Label ), MCP /00041901/ (View Mcp /00041901/ Review and Mcp /00041901/ Label ), MULTIBIONTA /00111701/ (View Multibionta /00111701/ Review and Multibionta /00111701/ Label ), EPOGEN (View Epogen Review and Epogen Label ). Patient was hospitalized.

6931261-2 | Depression, Extradural Haematoma
on Aug 05, 2010 Female patient from JAPAN , 60 years of age, was treated with Rebetol (View Usage). Patient had the following side effects: depression (What is depression?), extradural haematoma. Rebetol dosage: Po. During the same period patient was treated with INTRON A (Im) (View Intron A Review and Intron A Label ). Patient was hospitalized.

6920183-9 | Ulcerative Keratitis
on Jul 28, 2010 Female patient from JAPAN , 63 years of age, weighting 127.9 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: ulcerative keratitis. Rebetol dosage: 600 Mg; Po. During the same period patient was treated with INTERFERON (Iv) (View Interferon Review and Interferon Label ), PRAVASTAN (View Pravastan Review and Pravastan Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), PANCREAZE (View Pancreaze Review and Pancreaze Label ).

6919419-X | White Blood Cell Count Decreased
Patient was taking Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: white blood cell count decreased on Sep 29, 2009 from UNITED STATES Additional patient health information: Female patient , 56 years of age, . Rebetol dosage: Po.

6916537-7 | Depression, Extradural Haematoma
Adverse event was reported on Aug 02, 2010 by a Female patient taking Rebetol (View Usage) (Dosage: Po) . Location: JAPAN , 60 years of age, Patient had the following side effects: depression (What is depression?), extradural haematoma. During the same period patient was treated with INTRON A (Im) (View Intron A Review and Intron A Label ). Patient was hospitalized.

6874583-6 | Haemolytic Anaemia, Haemolytic Uraemic Syndrome, Headache, Platelet Count Decreased, Renal Tubular Necrosis
on Jul 15, 2010 Female patient from JAPAN , 51 years of age, weighting 134.5 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: haemolytic anaemia, haemolytic uraemic syndrome, headache (What is headache?), platelet count decreased, renal tubular necrosis. Rebetol dosage: 800 Mg;qd;po. During the same period patient was treated with INTERFERON (3 Miu;bid; Indrp) (View Interferon Review and Interferon Label ), RYTHMODAN (View Rythmodan Review and Rythmodan Label ), AMOXAN (View Amoxan Review and Amoxan Label ), CELLKAM (View Cellkam Review and Cellkam Label ), PZC (View Pzc Review and Pzc Label ), STOBRUN TAIYO (View Stobrun Taiyo Review and Stobrun Taiyo Label ). Patient was hospitalized.

6874565-4 | Blood Lactate Dehydrogenase Increased, Blood Pressure Increased, Haemolytic Anaemia, Oedema, Renal Failure Acute
on Jul 15, 2010 Female patient from JAPAN , 69 years of age, weighting 72.75 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactate dehydrogenase increased, blood pressure increased, haemolytic anaemia, oedema, renal failure acute. Rebetol dosage: 600 Mg;qd;po. During the same period patient was treated with INTERFERON (3 Miu;bid;indrp; 6 Miu;qd;indrp) (View Interferon Review and Interferon Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), RANITAC (View Ranitac Review and Ranitac Label ).

6863383-9 | Blood Pressure Increased, Bone Pain, Cough, Gingival Pain, Increased Tendency To Bruise, Insomnia, Myalgia, Nasal Congestion, Tongue Disorder
Patient was taking Rebetol (View Usage). Patient had the following side effects: blood pressure increased, bone pain, cough, gingival pain, increased tendency to bruise, insomnia, myalgia, nasal congestion, tongue disorder on Jul 13, 2010 from UNITED STATES Additional patient health information: Male patient , 35 years of age, . Rebetol dosage: .

6843574-3 | Abdominal Pain Upper, Asphyxia, Dizziness, Dyspnoea, Eye Swelling, Malaise, Pain In Extremity, Pruritus
Adverse event was reported on Jul 06, 2010 by a Female patient taking Rebetol (View Usage) (Dosage: 1000 Mg;qd;po) . Location: SPAIN , 55 years of age, After Rebetol was administered, patient had the following side effects: abdominal pain upper, asphyxia, dizziness (What is dizziness?), dyspnoea, eye swelling, malaise, pain in extremity, pruritus. During the same period patient was treated with PEGASYS (180 Mcg;qw;sc; 135 Mcg;qw;sc) (View Pegasys Review and Pegasys Label ).

6843427-0 | Haemolytic Uraemic Syndrome, Headache, Pyrexia
on Jul 06, 2010 Female patient from JAPAN , 51 years of age, weighting 134.5 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic uraemic syndrome, headache (What is headache?), pyrexia. Rebetol dosage: 800 Mg; Qd; Po. During the same period patient was treated with INTERFERON (3 Miu; Bid; Indrp) (View Interferon Review and Interferon Label ), DISOPYRAMIDE (View Disopyramide Review and Disopyramide Label ), AMOXAN (View Amoxan Review and Amoxan Label ), CELLKAM (View Cellkam Review and Cellkam Label ), PZC (View Pzc Review and Pzc Label ), STOBRUN TAIYO (View Stobrun Taiyo Review and Stobrun Taiyo Label ). Patient was hospitalized.

6843422-1 | Blood Creatine Phosphokinase Increased, Cough, Depression, Dermatitis Psoriasiform, Gastrointestinal Disorder, Insomnia, Musculoskeletal Stiffness
on Jul 06, 2010 Male patient from JAPAN , 43 years of age, weighting 180.8 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, cough, depression (What is depression?), dermatitis psoriasiform, gastrointestinal disorder, insomnia, musculoskeletal stiffness. Rebetol dosage: 1000 Mg; Qd; Po. During the same period patient was treated with PEG INTRON (120 Mcg; Qw; Sc) (View Peg-intron Review and Peg-intron Label ), INTERFERON (6 Miu; Tiw; Iv) (View Interferon Review and Interferon Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), LOXONIN (LOXOPROFEN SODIUM HYDRATE) (View Loxonin (loxoprofen Sodium Hydrate) Review and Loxonin (loxoprofen Sodium Hydrate) Label ), HOKUNALIN (TULOBUTEROL) (View Hokunalin (tulobuterol) Review and Hokunalin (tulobuterol) Label ), ALLELOCK (View Allelock Review and Allelock Label ), MYSLEE (View Myslee Review and Myslee Label ).

6837707-2 | Dyspnoea, Eye Swelling, Malaise, Pruritus
Patient was taking Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: dyspnoea, eye swelling, malaise, pruritus on Jun 25, 2010 from SPAIN Additional patient health information: Female patient , 55 years of age, . Rebetol dosage: 1000 Mg; Qd; Po. During the same period patient was treated with PEGASYS (180 Mcg; Qw; Sc, 135 Mcg; Qw; Sc) (View Pegasys Review and Pegasys Label ).

6831647-0 | Abdominal Pain Upper, Dizziness, Dyspnoea, Eye Swelling, Malaise, Pain In Extremity, Pruritus
Adverse event was reported on Jun 25, 2010 by a Female patient taking Rebetol (View Usage) (Dosage: 1000 Mg;qd;po) . Location: SPAIN , 55 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, dizziness (What is dizziness?), dyspnoea, eye swelling, malaise, pain in extremity, pruritus. During the same period patient was treated with PEGASYS (180 Mcg;qw;sc, 135 Mcg;qw;sc) (View Pegasys Review and Pegasys Label ).

6822149-6 | Blood Creatine Phosphokinase Increased, Cough, Depressive Symptom, Insomnia, Irritability, Musculoskeletal Stiffness, Psoriasis
on Jun 23, 2010 Male patient from JAPAN , 43 years of age, weighting 180.8 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, cough, depressive symptom, insomnia, irritability, musculoskeletal stiffness, psoriasis. Rebetol dosage: 1000 Mg; Qd; Po. During the same period patient was treated with PEG INTRON (120 Mcg; Qw; Im) (View Peg-intron Review and Peg-intron Label ), INTERFERON (6 Miu; Tiw; Iv) (View Interferon Review and Interferon Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), LOXONIN (LOXOPREOFEN SODIUM HYDRATE (View Loxonin (loxopreofen Sodium Hydrate Review and Loxonin (loxopreofen Sodium Hydrate Label ), HOKUNALIN (TULOBUTEROL) (View Hokunalin (tulobuterol) Review and Hokunalin (tulobuterol) Label ), ALLELOCK (View Allelock Review and Allelock Label ), MYSLEE (View Myslee Review and Myslee Label ).

6797883-7 | Asphyxia, Eye Swelling, Malaise, Pruritus
on Jun 10, 2010 Female patient from SPAIN , 55 years of age, was treated with Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: asphyxia, eye swelling, malaise, pruritus. Rebetol dosage: 1000 Mg; Qd; Po. During the same period patient was treated with PEGASYS (180 Mg; Qd; Sc, 135 Mg; Qd; Sc) (View Pegasys Review and Pegasys Label ).

6797401-3 | Haemolytic Anaemia, Platelet Count Decreased, Pyrexia, Renal Tubular Necrosis
Patient was taking Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic anaemia, platelet count decreased, pyrexia, renal tubular necrosis on Jun 16, 2010 from JAPAN Additional patient health information: Female patient , 51 years of age, weighting 134.5 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: 800 Mg; Qd; Po. During the same period patient was treated with INTERFERON (3 Miu; Bid; Indrp) (View Interferon Review and Interferon Label ), DISOPYRAMIDE (View Disopyramide Review and Disopyramide Label ), AMOXAN (View Amoxan Review and Amoxan Label ), CELLKAM (View Cellkam Review and Cellkam Label ), PZC (View Pzc Review and Pzc Label ), STOBRUN TAIYO (View Stobrun Taiyo Review and Stobrun Taiyo Label ). Patient was hospitalized.

6797380-9 | Blood Pressure Increased, Haemolytic Uraemic Syndrome, Malaise, Oedema
Adverse event was reported on Jun 16, 2010 by a Female patient taking Rebetol (View Usage) (Dosage: 600 Mg; Qd; Po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: JAPAN , 69 years of age, weighting 72.75 lb, Patient had the following side effects: blood pressure increased, haemolytic uraemic syndrome, malaise, oedema. During the same period patient was treated with INTERFERON (3 Miu; Bid; Indrp; 6 Miu; Qd; Indrp) (View Interferon Review and Interferon Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), RANITAC (View Ranitac Review and Ranitac Label ).

6770287-9 | Headache, Hyperemesis Gravidarum, Placenta Praevia, Premature Labour
on May 28, 2010 Female patient from UNITED STATES , 31 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: headache (What is headache?), hyperemesis gravidarum, placenta praevia, premature labour. Rebetol dosage: 800 Mg; Qd; Po. During the same period patient was treated with PEG INTRON (80 Mcg; Qw; Sc) (View Peg-intron Review and Peg-intron Label ), PRENATAL VITAMINS (View Prenatal Vitamins Review and Prenatal Vitamins Label ), METHADONE (View Methadone Review and Methadone Label ).

6769520-9 | Haemolytic Anaemia, Platelet Count Decreased, Pyrexia, Renal Failure Acute, Renal Tubular Necrosis
on Jun 03, 2010 Female patient from JAPAN , 51 years of age, weighting 134.5 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic anaemia, platelet count decreased, pyrexia, renal failure acute, renal tubular necrosis. Rebetol dosage: 800 Mg; Qd; Po. During the same period patient was treated with INTERFERON (3 Miu; Bid; Indrp) (View Interferon Review and Interferon Label ), DISOPYRAMIDE (View Disopyramide Review and Disopyramide Label ), AMOXAN (View Amoxan Review and Amoxan Label ), CELLKAM (View Cellkam Review and Cellkam Label ), PZC (View Pzc Review and Pzc Label ), STOBRUN TAIYO (View Stobrun Taiyo Review and Stobrun Taiyo Label ). Patient was hospitalized.

6769456-3 | Blood Lactate Dehydrogenase Increased, Blood Pressure Increased, Haemolytic Anaemia, Renal Impairment
Patient was taking Rebetol (View Usage). Patient had the following side effects: blood lactate dehydrogenase increased, blood pressure increased, haemolytic anaemia, renal impairment on Jun 03, 2010 from JAPAN Additional patient health information: Female patient , 69 years of age, weighting 72.75 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: 600 Mg; Qd; Po. During the same period patient was treated with INTERFERON (3 Miu; Bid; Indrp; 6 Miu;qd;indrp) (View Interferon Review and Interferon Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), RANITAC (View Ranitac Review and Ranitac Label ).

6769073-5 | Cerebral Infarction
Adverse event was reported on Jun 04, 2010 by a Male patient taking Rebetol (View Usage) (Dosage: ; Po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: JAPAN , 70 years of age, After Rebetol was administered, patient had the following side effects: cerebral infarction. During the same period patient was treated with INTERFERON (6 Miu; Qd; Iv, 6 Miu; Tiw; Iv) (View Interferon Review and Interferon Label ). Patient was hospitalized.

6758748-X | Cough, Decreased Appetite, Interstitial Lung Disease, Palpitations, Pancytopenia, Pyrexia
on May 19, 2010 Female patient from JAPAN , 52 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: cough, decreased appetite, interstitial lung disease, palpitations, pancytopenia, pyrexia. Rebetol dosage: 600 Mg;qd;po;po. During the same period patient was treated with INTRON A (Im) (View Intron A Review and Intron A Label ), INTERFERON (3 Miu;bid;iv) (View Interferon Review and Interferon Label ), LIVALO (CON.) (View Livalo (con.) Review and Livalo (con.) Label ), LOXONIN (CON.) (View Loxonin (con.) Review and Loxonin (con.) Label ), MUCOSTA (CON.) (View Mucosta (con.) Review and Mucosta (con.) Label ), MYSLEE (CON.) (View Myslee (con.) Review and Myslee (con.) Label ). Patient was hospitalized.

6755565-1 | Blood Pressure Increased, Haemolytic Uraemic Syndrome
on May 24, 2010 Female patient from JAPAN , 69 years of age, weighting 72.75 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient had the following side effects: blood pressure increased, haemolytic uraemic syndrome. Rebetol dosage: 600 Mg; Qd; Po. During the same period patient was treated with INTERFERON (3 Miu;bid;indrp, 6 Miu;qd;indrp) (View Interferon Review and Interferon Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), RANITAC (View Ranitac Review and Ranitac Label ).

6754823-4 | Abnormal Behaviour, Aggression, Condition Aggravated, Delirium, Dissociative Disorder, Hallucination, Poriomania, Schizophrenia
Patient was taking Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: abnormal behaviour, aggression, condition aggravated, delirium, dissociative disorder, hallucination, poriomania, schizophrenia on May 19, 2010 from JAPAN Additional patient health information: Female patient , 68 years of age, weighting 123.5 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: 600 Mg; Qd; Po. During the same period patient was treated with INTERFERON (6 Miu; Qd; Indrp, 6 Miu; Tiw; Indrp) (View Interferon Review and Interferon Label ), LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), PARIET (View Pariet Review and Pariet Label ), DESMOPRESSIN ACETATE (View Desmopressin Acetate Review and Desmopressin Acetate Label ), METLIGINE (View Metligine Review and Metligine Label ), DETRUSITOL (View Detrusitol Review and Detrusitol Label ). Patient was hospitalized.

6754753-8 | Hepatitis Acute
Adverse event was reported on May 19, 2010 by a Female patient taking Rebetol (View Usage) (Dosage: 400 Mg;bid;po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED KINGDOM , 45 years of age, weighting 135.8 lb, Patient experienced the following unwanted or unexpected effects: hepatitis acute. During the same period patient was treated with PEGASYS (180 Mcg;qw;sc) (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6753843-3 | Blepharitis, Blood Potassium Decreased, Erythema, Eye Inflammation, Skin Exfoliation, Skin Reaction
on May 21, 2010 Male patient from ITALY , 44 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient had the following side effects: blepharitis, blood potassium decreased, erythema, eye inflammation, skin exfoliation, skin reaction. Rebetol dosage: 1200 Mg; Qd; Po. During the same period patient was treated with PEGASYS (180 Mcg; Qw; Sc) (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6738835-2 | Interstitial Lung Disease, Pyrexia, Rales, White Blood Cell Count Increased
on May 11, 2010 Female patient from JAPAN , 50 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: interstitial lung disease, pyrexia, rales, white blood cell count increased. Rebetol dosage: 600 Mg;qd;po. During the same period patient was treated with INTERFERON (6 Miu; Iv) (View Interferon Review and Interferon Label ), LIVALO (View Livalo Review and Livalo Label ). Patient was hospitalized.

6721283-9 | Blood Lactate Dehydrogenase Increased, Blood Pressure Increased, Haemolytic Anaemia, Renal Impairment
Patient was taking Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactate dehydrogenase increased, blood pressure increased, haemolytic anaemia, renal impairment on May 06, 2010 from JAPAN Additional patient health information: Female patient , 69 years of age, weighting 72.75 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: 600 Mg; Qd; Po. During the same period patient was treated with INTERFERON (3 Miu; Bid; Indrp, 6 Miu; Qd; Indrp) (View Interferon Review and Interferon Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), RANITAC (View Ranitac Review and Ranitac Label ).

6718669-5 | Trisomy 21
Adverse event was reported on Apr 26, 2010 by a Male patient taking Rebetol (View Usage) (Dosage: Trpl) . Location: UNITED STATES , weighting 6.31 lb, Patient had the following side effects: trisomy 21. During the same period patient was treated with INTRON A (Trpl) (View Intron A Review and Intron A Label ).

6717384-1 | Haemolytic Anaemia, Platelet Count Decreased, Pyrexia, Renal Tubular Necrosis
on Apr 27, 2010 Female patient from JAPAN , 51 years of age, weighting 134.5 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: haemolytic anaemia, platelet count decreased, pyrexia, renal tubular necrosis. Rebetol dosage: 800 Mg;qd;po. During the same period patient was treated with INTERFERON (3 Miu;bid;indrp) (View Interferon Review and Interferon Label ), DISOPYRAMIDE (View Disopyramide Review and Disopyramide Label ), AMOXAN (View Amoxan Review and Amoxan Label ), CELLKAM (View Cellkam Review and Cellkam Label ), PZC (View Pzc Review and Pzc Label ), STOBRUN TAIYO (View Stobrun Taiyo Review and Stobrun Taiyo Label ). Patient was hospitalized.

6710485-3 | Ulcerative Keratitis
on Apr 22, 2010 Female patient from JAPAN , 63 years of age, weighting 126.8 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: ulcerative keratitis. Rebetol dosage: Po. During the same period patient was treated with FERON (INTERFERON) (Iv) (View Feron (interferon) Review and Feron (interferon) Label ).

6703397-2 | Erythema Nodosum, Tuberculosis
Patient was taking Rebetol (View Usage). Patient had the following side effects: erythema nodosum, tuberculosis (What is tuberculosis?) on Apr 19, 2010 from GREECE Additional patient health information: Female patient , 70 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: 1000 Mg;qd;. During the same period patient was treated with PEGINTERFERON ALFA 2A (180 Mg;qw;) (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ), RIBAVIRIN (1000 Mg;qd;) (View Ribavirin Review and Ribavirin Label ).

6672042-7 | Erythema Nodosum, Tuberculosis
Adverse event was reported on Mar 24, 2010 by a Female patient taking Rebetol (View Usage) (Dosage: 1000 Mg, Qd;) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: GREECE , 70 years of age, After Rebetol was administered, patient had the following side effects: erythema nodosum, tuberculosis (What is tuberculosis?). During the same period patient was treated with PEGINTERFERON ALFA 2A (180 Mg, Qw;) (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ).

6662550-7 | Abnormal Behaviour, Aggression, Condition Aggravated, Hallucination, Visual, Poriomania, Schizophrenia
on Mar 19, 2010 Female patient from JAPAN , 68 years of age, weighting 123.5 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, aggression, condition aggravated, hallucination, visual, poriomania, schizophrenia. Rebetol dosage: 600 Mg;qd;po. During the same period patient was treated with INTERFERON (6 Miu;qd;indrp; 6 Miu;tiw,indrp) (View Interferon Review and Interferon Label ), LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), PARIET (View Pariet Review and Pariet Label ), DESMOPRESSIN ACETATE (View Desmopressin Acetate Review and Desmopressin Acetate Label ), METIGINE (View Metigine Review and Metigine Label ), DETRUSITOL (View Detrusitol Review and Detrusitol Label ). Patient was hospitalized.

6653951-1 | Abortion Spontaneous, Pregnancy
on Mar 12, 2010 Female patient from SPAIN , 34 years of age, weighting 198.4 lb, was treated with Rebetol (View Usage). Patient had the following side effects: abortion spontaneous, pregnancy (What is pregnancy?). Rebetol dosage: . During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ).

6642707-1 | Blood Creatinine Increased, Haemolytic Anaemia, Platelet Count Decreased
Patient was taking Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: blood creatinine increased, haemolytic anaemia, platelet count decreased on Mar 09, 2010 from JAPAN Additional patient health information: Female patient , 50 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: 800 Mg;qd;po. During the same period patient was treated with INTERFERON (3 Miu;bid;indrp) (View Interferon Review and Interferon Label ). Patient was hospitalized.

6636260-6 | Ulcerative Keratitis
Adverse event was reported on Mar 02, 2010 by a Female patient taking Rebetol (View Usage) (Dosage: Po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: JAPAN , 63 years of age, weighting 126.8 lb, Patient experienced the following unwanted or unexpected effects: ulcerative keratitis. During the same period patient was treated with INTERFERON (Iv) (View Interferon Review and Interferon Label ).

6634071-9 | Blood Creatinine Increased, Haemolytic Anaemia
on Mar 03, 2010 Female patient from JAPAN , 70 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient had the following side effects: blood creatinine increased, haemolytic anaemia. Rebetol dosage: 600 Mg; Qd; Po. During the same period patient was treated with FERON (INTERFERON) (3 Miu; Bid; Indrp, 6 Miu; Qd; Indrp) (View Feron (interferon) Review and Feron (interferon) Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), RANITAC (View Ranitac Review and Ranitac Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

6620037-1 | Skin Ulcer
on Feb 25, 2010 Male patient from JAPAN , 71 years of age, was treated with Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: skin ulcer. Rebetol dosage: . During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ).

6612497-7 | Abnormal Behaviour, Aggression, Condition Aggravated, Dissociative Disorder, Hallucination, No Therapeutic Response, Poriomania, Schizophrenia, Speech Disorder
Patient was taking Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, aggression, condition aggravated, dissociative disorder, hallucination, no therapeutic response, poriomania, schizophrenia, speech disorder on Feb 17, 2010 from JAPAN Additional patient health information: Female patient , 68 years of age, weighting 123.5 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: 600 Mg; Qd; Po. During the same period patient was treated with INTERFERON (6 Miu; Qd; Indrp, 6 Miu; Tiw; Indrp) (View Interferon Review and Interferon Label ), LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), PARIET (View Pariet Review and Pariet Label ), DESMOPRESSIN ACETATE (View Desmopressin Acetate Review and Desmopressin Acetate Label ), METLIGINE (View Metligine Review and Metligine Label ), DETRUSITOL (View Detrusitol Review and Detrusitol Label ). Patient was hospitalized.

6599696-8 | Congestive Cardiomyopathy
Adverse event was reported on Feb 08, 2010 by a Male patient taking Rebetol (View Usage) (Dosage: 1200 Mg;bid;po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: SPAIN , 48 years of age, Patient had the following side effects: congestive cardiomyopathy. During the same period patient was treated with PEGASYS (180 Mcg; Qw; Sc) (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

6593807-6 | Persecutory Delusion, Refusal Of Treatment By Patient, Unevaluable Event
on Feb 01, 2010 Female patient from FRANCE , 30 years of age, weighting 123.5 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). After Rebetol was administered, patient had the following side effects: persecutory delusion, refusal of treatment by patient, unevaluable event. Rebetol dosage: 800 Mg;qd;po. During the same period patient was treated with PEGASYS (135 Mcg;qw;sc) (View Pegasys Review and Pegasys Label ), COPEGUS (RIBAVIRIN / 0081670/) (Po) (View Copegus (ribavirin / 0081670/) Review and Copegus (ribavirin / 0081670/) Label ), TERCIAN (CON.) (View Tercian (con.) Review and Tercian (con.) Label ), LAROXYL (CON.) (View Laroxyl (con.) Review and Laroxyl (con.) Label ), LEPTICUR (CON.) (View Lepticur (con.) Review and Lepticur (con.) Label ), INTERFERON (PREV.) (View Interferon (prev.) Review and Interferon (prev.) Label ). Patient was hospitalized.

6592965-7 | Cardiac Failure Congestive, Cardiomegaly, Condition Aggravated, Cough, Face Oedema, Oedema Peripheral, Pleural Effusion, Weight Increased
on Feb 04, 2010 Female patient from JAPAN , 68 years of age, weighting 97.00 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Rebetol (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, cardiomegaly, condition aggravated, cough, face oedema, oedema peripheral, pleural effusion, weight increased. Rebetol dosage: 600 Mg; Qd; Po. During the same period patient was treated with INTERFERON (6 Miu; Qd; Indrp, 6 Miu; Tiw; Indrp) (View Interferon Review and Interferon Label ), EVISTA (View Evista Review and Evista Label ).

6578725-1 | Folate Deficiency, Hepatitis Cholestatic, Hepatocellular Injury, Idiopathic Thrombocytopenic Purpura, Serum Ferritin Increased
Patient was taking Rebetol (View Usage). Patient had the following side effects: folate deficiency, hepatitis cholestatic, hepatocellular injury, idiopathic thrombocytopenic purpura, serum ferritin increased on Jan 25, 2010 from FRANCE Additional patient health information: Male patient , 59 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Rebetol dosage: Po. During the same period patient was treated with PEGASYS (Iv) (View Pegasys Review and Pegasys Label ), AMANTADINE HCL (Po) (View Amantadine Hcl Review and Amantadine Hcl Label ). Patient was hospitalized.